To use spinal opioids appropriately, it is necessary to understand the pharmacokinetics and clinical pharmacology of these drugs including which opioids produce selective spinal analgesia and which do not. Briefl y, spinal selectivity is highest for hydrophilic opioids and lowest for lipophilic opioids. These differences result from natural variations in the bioavailability of opioids at opioid receptors in the spinal cord. The bioavailability differs because lipophilic drugs are more rapidly cleared into the plasma from epidural and intrathecal spaces, than hydrophilic drugs; consequently, they produce earlier supraspinal side effects and have a considerably shorter duration of analgesic action concerning morphine which can produce delay supraspinal adverse effects.
Morphine is probably the most spinally selective opioid currently used in the intrathecal and epidural spaces for the management of postoperative pain. Continuous epidural administration of fentanyl offers little or no benefi t over the intravenous route. Finally, epidurally administered sufentanil and alfentanil appear to produce analgesia by systemic uptake and redistribution to brainstem opioid receptors.
Keywords:
Published on: Jun 15, 2017 Pages: 21-26
Full Text PDF
Full Text HTML
DOI: 10.17352/ojpm.000005
CrossMark
Publons
Harvard Library HOLLIS
Search IT
Semantic Scholar
Get Citation
Base Search
Scilit
OAI-PMH
ResearchGate
Academic Microsoft
GrowKudos
Universite de Paris
UW Libraries
SJSU King Library
SJSU King Library
NUS Library
McGill
DET KGL BIBLiOTEK
JCU Discovery
Universidad De Lima
WorldCat
VU on WorldCat